Loading...
Header Logo
Keywords
Last Name
Institution

Dr Allan James Saul

TitleInstitute Director
InstitutionGSK Vaccines Institute for Global Health
AddressSiena
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gerke C, Colucci AM, Giannelli C, Sanzone S, Vitali CG, Sollai L, Rossi O, Martin LB, Auerbach J, Di Cioccio V, Saul A. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. PLoS One. 2015; 10(8):e0134478. PMID: 26248044; PMCID: PMC4527750.
    2. Onsare RS, Micoli F, Lanzilao L, Alfini R, Okoro CK, Muigai AW, Revathi G, Saul A, Kariuki S, MacLennan CA, Rondini S. Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from Kenya. PLoS Negl Trop Dis. 2015 Mar; 9(3):e0003573. PMID: 25739091; PMCID: PMC4352093.
    3. MacLennan CA, Saul A. Vaccines against poverty. Proc Natl Acad Sci U S A. 2014 Aug 26; 111(34):12307-12. PMID: 25136089; PMCID: PMC4151718.
    4. Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Lancet Infect Dis. 2014 Feb; 14(2):119-29. PMID: 24290843.
      View in: PubMed
    5. Saul A, Smith T, Maire N. Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier state. PLoS One. 2013; 8(9):e74097. PMID: 24040177; PMCID: PMC3769365.
    6. Rondini S, Micoli F, Lanzilao L, Pisoni I, Di Cioccio V, Saul AJ, Martin LB. Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM(197) glycoconjugate vaccine against Salmonella Typhi. J Infect Dev Ctries. 2012 Nov 26; 6(11):763-73. PMID: 23277501.
      View in: PubMed
    7. Micoli F, Rondini S, Gavini M, Lanzilao L, Medaglini D, Saul A, Martin LB. O:2-CRM(197) conjugates against Salmonella Paratyphi A. PLoS One. 2012; 7(11):e47039. PMID: 23144798; PMCID: PMC3492368.
    8. Micoli F, Rondini S, Gavini M, Pisoni I, Lanzilao L, Colucci AM, Giannelli C, Pippi F, Sollai L, Pinto V, Berti F, MacLennan CA, Martin LB, Saul A. A scalable method for O-antigen purification applied to various Salmonella serovars. Anal Biochem. 2013 Mar 01; 434(1):136-45. PMID: 23142430; PMCID: PMC3967520.
    9. Zhu D, Qian F, Wu Y, Jones DS, Rowe C, Narum DL, Duffy P, Miller LH, Saul A. Determination of protein concentration for protein-protein conjugates using ultraviolet absorption. J Immunol Methods. 2013 Jan 31; 387(1-2):317-21. PMID: 23098838; PMCID: PMC3529773.
    10. Micoli F, Rondini S, Pisoni I, Giannelli C, Di Cioccio V, Costantino P, Saul A, Martin LB. Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi. Vaccine. 2012 Jan 20; 30(5):853-61. PMID: 22172503.
      View in: PubMed
    11. Zhu D, Huang S, McClellan H, Dai W, Syed NR, Gebregeorgis E, Rausch KM, Mullen GE, Long C, Martin LB, Narum D, Duffy P, Miller LH, Saul A. Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer. Vaccine. 2012 Jan 05; 30(2):189-94. PMID: 22107848; PMCID: PMC3246088.
    12. van Damme P, Kafeja F, Anemona A, Basile V, Hilbert AK, De Coster I, Rondini S, Micoli F, Qasim Khan RM, Marchetti E, Di Cioccio V, Saul A, Martin LB, Podda A. Safety, immunogenicity and dose ranging of a new Vi-CRM197 conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults. PLoS One. 2011; 6(9):e25398. PMID: 21980445; PMCID: PMC3184126.
    13. Rondini S, Micoli F, Lanzilao L, Hale C, Saul AJ, Martin LB. Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi. Clin Vaccine Immunol. 2011 Mar; 18(3):460-8. PMID: 21248155; PMCID: PMC3067394.
    14. Micoli F, Rondini S, Pisoni I, Proietti D, Berti F, Costantino P, Rappuoli R, Szu S, Saul A, Martin LB. Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi. Vaccine. 2011 Jan 17; 29(4):712-20. PMID: 21115057; PMCID: PMC4163788.
    15. Podda A, Saul AJ, Arora R, Bhutta Z, Sinha A, Gaind R, Singhal T, Saha S, Brooks A, Martin LB, Amdekar Y, Chitkara AJ, Shieh M, Kapur AN, Chugh TD. Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009. J Infect Dev Ctries. 2010 Jun 30; 4(6):404-11. PMID: 20601795.
      View in: PubMed
    16. Zhu D, Saul A, Huang S, Martin LB, Miller LH, Rausch KM. Use of o-phthalaldehyde assay to determine protein contents of Alhydrogel-based vaccines. Vaccine. 2009 Oct 09; 27(43):6054-9. PMID: 19660590; PMCID: PMC2753737.
    17. Ellis RD, Mullen GE, Pierce M, Martin LB, Miura K, Fay MP, Long CA, Shaffer D, Saul A, Miller LH, Durbin AP. A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals. Vaccine. 2009 Jun 24; 27(31):4104-9. PMID: 19410624; PMCID: PMC2722923.
    18. Zhu D, Huang S, Gebregeorgis E, McClellan H, Dai W, Miller L, Saul A. Development of a Direct Alhydrogel Formulation Immunoassay (DAFIA). J Immunol Methods. 2009 May 15; 344(1):73-8. PMID: 19328804; PMCID: PMC2712229.
    19. Sagara I, Dicko A, Ellis RD, Fay MP, Diawara SI, Assadou MH, Sissoko MS, Kone M, Diallo AI, Saye R, Guindo MA, Kante O, Niambele MB, Miura K, Mullen GE, Pierce M, Martin LB, Dolo A, Diallo DA, Doumbo OK, Miller LH, Saul A. A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. Vaccine. 2009 May 18; 27(23):3090-8. PMID: 19428923; PMCID: PMC2713037.
    20. Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL, Lambert L, Miller LH, Long CA, Saul A, Narum DL. Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure. Mol Biochem Parasitol. 2009 Mar; 164(1):45-56. PMID: 19073223; PMCID: PMC3633458.
    21. Mullen GE, Ellis RD, Miura K, Malkin E, Nolan C, Hay M, Fay MP, Saul A, Zhu D, Rausch K, Moretz S, Zhou H, Long CA, Miller LH, Treanor J. Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria. PLoS One. 2008 Aug 13; 3(8):e2940. PMID: 18698359; PMCID: PMC2491586.
    22. Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One. 2008 Jul 09; 3(7):e2636. PMID: 18612426; PMCID: PMC2440546.
    23. Qian F, Rausch KM, Muratova O, Zhou H, Song G, Diouf A, Lambert L, Narum DL, Wu Y, Saul A, Miller LH, Long CA, Mullen GE. Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders. Vaccine. 2008 May 12; 26(20):2521-7. PMID: 18423804; PMCID: PMC2426823.
    24. Dicko A, Sagara I, Ellis RD, Miura K, Guindo O, Kamate B, Sogoba M, Niambelé MB, Sissoko M, Baby M, Dolo A, Mullen GE, Fay MP, Pierce M, Diallo DA, Saul A, Miller LH, Doumbo OK. Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children. PLoS One. 2008 Feb 13; 3(2):e1563. PMID: 18270560; PMCID: PMC2216433.
    25. Saul A. Efficacy model for mosquito stage transmission blocking vaccines for malaria. Parasitology. 2008 Nov; 135(13):1497-506. PMID: 18257944.
      View in: PubMed
    26. Dicko A, Sagara I, Diemert D, Sogoba M, Niambele MB, Dao A, Dolo G, Yalcouye D, Diallo DA, Saul A, Miller LH, Toure YT, Klion AD, Doumbo OK. Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity. Am J Trop Med Hyg. 2007 Dec; 77(6):1028-33. PMID: 18165516.
      View in: PubMed
    27. Miura K, Orcutt AC, Muratova OV, Miller LH, Saul A, Long CA. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine. 2008 Jan 10; 26(2):193-200. PMID: 18054414; PMCID: PMC2253722.
    28. Dicko A, Diemert DJ, Sagara I, Sogoba M, Niambele MB, Assadou MH, Guindo O, Kamate B, Baby M, Sissoko M, Malkin EM, Fay MP, Thera MA, Miura K, Dolo A, Diallo DA, Mullen GE, Long CA, Saul A, Doumbo O, Miller LH. Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians. PLoS One. 2007 Oct 17; 2(10):e1045. PMID: 17940609; PMCID: PMC2013939.
    29. Jiang G, Charoenvit Y, Moreno A, Baraceros MF, Banania G, Richie N, Abot S, Ganeshan H, Fallarme V, Patterson NB, Geall A, Weiss WR, Strobert E, Caro-Aquilar I, Lanar DE, Saul A, Martin LB, Gowda K, Morrissette CR, Kaslow DC, Carucci DJ, Galinski MR, Doolan DL. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. Malar J. 2007 Oct 09; 6:135. PMID: 17925026; PMCID: PMC2147027.
    30. Saul A, Hensmann M, Sattabongkot J, Collins WE, Barnwell JW, Langermans JA, Wu Y, Long CA, Dubovsky F, Thomas AW. Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720. Parasite Immunol. 2007 Oct; 29(10):525-33. PMID: 17883455.
      View in: PubMed
    31. Saul A. Mosquito stage, transmission blocking vaccines for malaria. Curr Opin Infect Dis. 2007 Oct; 20(5):476-81. PMID: 17762780.
      View in: PubMed
    32. Saul A, Fay MP. Human immunity and the design of multi-component, single target vaccines. PLoS One. 2007 Sep 05; 2(9):e850. PMID: 17786221; PMCID: PMC1952173.
    33. Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malar J. 2007 Aug 08; 6:107. PMID: 17686163; PMCID: PMC1971714.
    34. Mullen GE, Aebig JA, Dobrescu G, Rausch K, Lambert L, Long CA, Miles AP, Saul A. Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigen. Vaccine. 2007 Jul 20; 25(29):5343-7. PMID: 17566616; PMCID: PMC1997297.
    35. Aebig JA, Mullen GE, Dobrescu G, Rausch K, Lambert L, Ajose-Popoola O, Long CA, Saul A, Miles AP. Formulation of vaccines containing CpG oligonucleotides and alum. J Immunol Methods. 2007 Jun 30; 323(2):139-46. PMID: 17512533; PMCID: PMC2001166.
    36. Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB. Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria. PLoS Clin Trials. 2007; 2(4):e12. PMID: 17415408; PMCID: PMC1847697.
    37. Qian F, Wu Y, Muratova O, Zhou H, Dobrescu G, Duggan P, Lynn L, Song G, Zhang Y, Reiter K, MacDonald N, Narum DL, Long CA, Miller LH, Saul A, Mullen GE. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates. Vaccine. 2007 May 16; 25(20):3923-33. PMID: 17428587; PMCID: PMC1940062.
    38. Saul A. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them? J Infect Dis. 2007 Jan 15; 195(2):171-3. PMID: 17191161.
      View in: PubMed
    39. Wu Y, Przysiecki C, Flanagan E, Bello-Irizarry SN, Ionescu R, Muratova O, Dobrescu G, Lambert L, Keister D, Rippeon Y, Long CA, Shi L, Caulfield M, Shaw A, Saul A, Shiver J, Miller LH. Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proc Natl Acad Sci U S A. 2006 Nov 28; 103(48):18243-8. PMID: 17110440; PMCID: PMC1636993.
    40. Ramjanee S, Robertson JS, Franke-Fayard B, Sinha R, Waters AP, Janse CJ, Wu Y, Blagborough AM, Saul A, Sinden RE. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials. Vaccine. 2007 Jan 15; 25(5):886-94. PMID: 17049690.
      View in: PubMed
    41. Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Infect Immun. 2006 Aug; 74(8):4573-80. PMID: 16861644; PMCID: PMC1539572.
    42. Shimp RL, Martin LB, Zhang Y, Henderson BS, Duggan P, MacDonald NJ, Lebowitz J, Saul A, Narum DL. Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tag. Protein Expr Purif. 2006 Nov; 50(1):58-67. PMID: 16884920.
      View in: PubMed
    43. Wille-Reece U, Flynn BJ, Loré K, Koup RA, Miles AP, Saul A, Kedl RM, Mattapallil JJ, Weiss WR, Roederer M, Seder RA. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J Exp Med. 2006 May 15; 203(5):1249-58. PMID: 16636134; PMCID: PMC2121207.
    44. Collins WE, Barnwell JW, Sullivan JS, Nace D, Williams T, Bounngaseng A, Roberts J, Strobert E, McClure H, Saul A, Long CA. Assessment of transmission-blocking activity of candidate Pvs25 vaccine using gametocytes from chimpanzees. Am J Trop Med Hyg. 2006 Feb; 74(2):215-21. PMID: 16474073.
      View in: PubMed
    45. Mullen GE, Giersing BK, Ajose-Popoola O, Davis HL, Kothe C, Zhou H, Aebig J, Dobrescu G, Saul A, Long CA. Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide. Vaccine. 2006 Mar 24; 24(14):2497-505. PMID: 16434128.
      View in: PubMed
    46. Saxena AK, Singh K, Su HP, Klein MM, Stowers AW, Saul AJ, Long CA, Garboczi DN. The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms. Nat Struct Mol Biol. 2006 Jan; 13(1):90-1. PMID: 16327807.
      View in: PubMed
    47. Arévalo-Herrera M, Solarte Y, Yasnot MF, Castellanos A, Rincón A, Saul A, Mu J, Long C, Miller L, Herrera S. Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein. Am J Trop Med Hyg. 2005 Nov; 73(5 Suppl):32-7. PMID: 16291764.
      View in: PubMed
    48. Miller LH, Saul A, Mahanty S. Revisiting Freund's incomplete adjuvant for vaccines in the developing world. Trends Parasitol. 2005 Sep; 21(9):412-4. PMID: 16043410.
      View in: PubMed
    49. Zhu D, Saul AJ, Miles AP. A quantitative slot blot assay for host cell protein impurities in recombinant proteins expressed in E. coli. J Immunol Methods. 2005 Nov 30; 306(1-2):40-50. PMID: 16137696.
      View in: PubMed
    50. Giersing B, Miura K, Shimp R, Wang J, Zhou H, Orcutt A, Stowers A, Saul A, Miller LH, Long C, Singh S. posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate. Infect Immun. 2005 Jul; 73(7):3963-70. PMID: 15972483; PMCID: PMC1168543.
    51. Wang J, Nguyen V, Glen J, Henderson B, Saul A, Miller LH. Improved yield of recombinant merozoite Surface protein 3 (MSP3) from Pichia pastoris using chemically defined media. Biotechnol Bioeng. 2005 Jun 30; 90(7):838-47. PMID: 15849695.
      View in: PubMed
    52. Malkin EM, Diemert DJ, McArthur JH, Perreault JR, Miles AP, Giersing BK, Mullen GE, Orcutt A, Muratova O, Awkal M, Zhou H, Wang J, Stowers A, Long CA, Mahanty S, Miller LH, Saul A, Durbin AP. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect Immun. 2005 Jun; 73(6):3677-85. PMID: 15908397; PMCID: PMC1111886.
    53. Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine. 2005 May 02; 23(24):3131-8. PMID: 15837212.
      View in: PubMed
    54. Saul A, Lawrence G, Allworth A, Elliott S, Anderson K, Rzepczyk C, Martin LB, Taylor D, Eisen DP, Irving DO, Pye D, Crewther PE, Hodder AN, Murphy VJ, Anders RF. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. Vaccine. 2005 Apr 27; 23(23):3076-83. PMID: 15811655.
      View in: PubMed
    55. Miles AP, McClellan HA, Rausch KM, Zhu D, Whitmore MD, Singh S, Martin LB, Wu Y, Giersing BK, Stowers AW, Long CA, Saul A. Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations. Vaccine. 2005 Mar 31; 23(19):2530-9. PMID: 15752840.
      View in: PubMed
    56. van der Kolk M, De Vlas SJ, Saul A, van de Vegte-Bolmer M, Eling WM, Sauerwein RW, Sauerwein W. Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology. 2005 Jan; 130(Pt 1):13-22. PMID: 15700753.
      View in: PubMed
    57. Flück C, Smith T, Beck HP, Irion A, Betuela I, Alpers MP, Anders R, Saul A, Genton B, Felger I. Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun. 2004 Nov; 72(11):6300-5. PMID: 15501757; PMCID: PMC523016.
    58. Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, Druilhe P, Giersing BK, Saul A, Heppner DG, Kester KE, Lanar DE, Lyon J, Hill AV, Pan W, Cohen JD. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):239-47. PMID: 15331843.
      View in: PubMed
    59. Saul A. The mosquito's innate sting. Nat Med. 2004 May; 10(5):455-7. PMID: 15122241.
      View in: PubMed
    60. Johnson AH, Leke RG, Mendell NR, Shon D, Suh YJ, Bomba-Nkolo D, Tchinda V, Kouontchou S, Thuita LW, van der Wel AM, Thomas A, Stowers A, Saul A, Zhou A, Taylor DW, Quakyi IA. Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1. Infect Immun. 2004 May; 72(5):2762-71. PMID: 15102786; PMCID: PMC387839.
    61. Saxena AK, Saul A, Garboczi DN. Crystallization and preliminary X-ray analysis of the Plasmodium vivax sexual stage 25 kDa protein Pvs25, a transmission-blocking vaccine candidate for malaria. Acta Crystallogr D Biol Crystallogr. 2004 Apr; 60(Pt 4):706-8. PMID: 15039560.
      View in: PubMed
    62. Hastings IM, Paget-McNicol S, Saul A. Can mutation and selection explain virulence in human P. falciparum infections? Malar J. 2004 Mar 02; 3:2. PMID: 14992697; PMCID: PMC394339.
    63. Genton B, Al-Yaman F, Betuela I, Anders RF, Saul A, Baea K, Mellombo M, Taraika J, Brown GV, Pye D, Irving DO, Felger I, Beck HP, Smith TA, Alpers MP. Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children. Vaccine. 2003 Dec 08; 22(1):30-41. PMID: 14604568.
      View in: PubMed
    64. Smith FM, Vearing C, Lackmann M, Treutlein H, Himanen J, Chen K, Saul A, Nikolov D, Boyd AW. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J Biol Chem. 2004 Mar 05; 279(10):9522-31. PMID: 14660665.
      View in: PubMed
    65. Singh S, Kennedy MC, Long CA, Saul AJ, Miller LH, Stowers AW. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1. Infect Immun. 2003 Dec; 71(12):6766-74. PMID: 14638762; PMCID: PMC308882.
    66. Mahanty S, Saul A, Miller LH. Progress in the development of recombinant and synthetic blood-stage malaria vaccines. J Exp Biol. 2003 Nov; 206(Pt 21):3781-8. PMID: 14506213.
      View in: PubMed
    67. Gratepanche S, Gamain B, Smith JD, Robinson BA, Saul A, Miller LH. Induction of crossreactive antibodies against the Plasmodium falciparum variant protein. Proc Natl Acad Sci U S A. 2003 Oct 28; 100(22):13007-12. PMID: 14569009; PMCID: PMC240735.
    68. Saul A. Zooprophylaxis or zoopotentiation: the outcome of introducing animals on vector transmission is highly dependent on the mosquito mortality while searching. Malar J. 2003 Sep 19; 2:32. PMID: 14565850; PMCID: PMC222927.
    69. Fischer K, Chavchich M, Huestis R, Wilson DW, Kemp DJ, Saul A. Ten families of variant genes encoded in subtelomeric regions of multiple chromosomes of Plasmodium chabaudi, a malaria species that undergoes antigenic variation in the laboratory mouse. Mol Microbiol. 2003 Jun; 48(5):1209-23. PMID: 12787350.
      View in: PubMed
    70. Stowers AW, Kennedy MC, Keegan BP, Saul A, Long CA, Miller LH. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria. Infect Immun. 2002 Dec; 70(12):6961-7. PMID: 12438375; PMCID: PMC133036.
    71. Kennedy MC, Wang J, Zhang Y, Miles AP, Chitsaz F, Saul A, Long CA, Miller LH, Stowers AW. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect Immun. 2002 Dec; 70(12):6948-60. PMID: 12438374; PMCID: PMC133034.
    72. Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, Cloonan N, Anderson K, Mahakunkijcharoen Y, Martin LB, Wilson D, Elliott S, Elliott S, Eisen DP, Weinberg JB, Saul A, Good MF. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet. 2002 Aug 24; 360(9333):610-7. PMID: 12241933.
      View in: PubMed
    73. Peters JM, Chen N, Gatton M, Korsinczky M, Fowler EV, Manzetti S, Saul A, Cheng Q. Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum. Antimicrob Agents Chemother. 2002 Aug; 46(8):2435-41. PMID: 12121915; PMCID: PMC127342.
    74. Peters J, Fowler E, Gatton M, Chen N, Saul A, Cheng Q. High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteers. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10689-94. PMID: 12142467; PMCID: PMC125014.
    75. Eisen DP, Saul A, Fryauff DJ, Reeder JC, Coppel RL. Alterations in Plasmodium falciparum genotypes during sequential infections suggest the presence of strain specific immunity. Am J Trop Med Hyg. 2002 Jul; 67(1):8-16. PMID: 12363069.
      View in: PubMed
    76. Miles AP, Zhang Y, Saul A, Stowers AW. Large-scale purification and characterization of malaria vaccine candidate antigen Pvs25H for use in clinical trials. Protein Expr Purif. 2002 Jun; 25(1):87-96. PMID: 12071703.
      View in: PubMed
    77. Egan AF, Fabucci ME, Saul A, Kaslow DC, Miller LH. Aotus New World monkeys: model for studying malaria-induced anemia. Blood. 2002 May 15; 99(10):3863-6. PMID: 11986251.
      View in: PubMed
    78. Miller LH, Hudson-Taylor D, Gamain B, Saul AJ. Definition of the minimal domain of CIDR1alpha of Plasmodium falciparum PfEMP1 for binding CD36. Mol Biochem Parasitol. 2002 Apr 09; 120(2):321-3. PMID: 11897140.
      View in: PubMed
    79. Paget-McNicol S, Gatton M, Hastings I, Saul A. The Plasmodium falciparum var gene switching rate, switching mechanism and patterns of parasite recrudescence described by mathematical modelling. Parasitology. 2002 Mar; 124(Pt 3):225-35. PMID: 11922425.
      View in: PubMed
    80. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis. 2002 Mar 15; 185(6):820-7. PMID: 11920300.
      View in: PubMed
    81. Hisaeda H, Saul A, Reece JJ, Kennedy MC, Long CA, Miller LH, Stowers AW. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys. J Infect Dis. 2002 Mar 01; 185(5):657-64. PMID: 11865423.
      View in: PubMed
    82. Richie TL, Saul A. Progress and challenges for malaria vaccines. Nature. 2002 Feb 07; 415(6872):694-701. PMID: 11832958.
      View in: PubMed
    83. Stowers AW, Chen Lh LH, Zhang Y, Kennedy MC, Zou L, Lambert L, Rice TJ, Kaslow DC, Saul A, Long CA, Meade H, Miller LH. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):339-44. PMID: 11752405; PMCID: PMC117562.
    84. Hisaeda H, Collins WE, Saul A, Stowers AW. Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism. Vaccine. 2001 Dec 12; 20(5-6):763-70. PMID: 11738740.
      View in: PubMed
    85. Tchavtchitch M, Fischer K, Huestis R, Saul A. The sequence of a 200 kb portion of a Plasmodium vivax chromosome reveals a high degree of conservation with Plasmodium falciparum chromosome 3. Mol Biochem Parasitol. 2001 Dec; 118(2):211-22. PMID: 11738711.
      View in: PubMed
    86. Gatton ML, Hogarth W, Saul A. Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections. Parasitology. 2001 Dec; 123(Pt 6):537-46. PMID: 11814040.
      View in: PubMed
    87. Bell D, Go R, Miguel C, Walker J, Cacal L, Saul A. Diagnosis of malaria in a remote area of the Philippines: comparison of techniques and their acceptance by health workers and the community. Bull World Health Organ. 2001; 79(10):933-41. PMID: 11693975; PMCID: PMC2566678.
    88. Saul A, Miller LH. A robust neutralization test for Plasmodium falciparum malaria. J Exp Med. 2001 Jun 18; 193(12):F51-4. PMID: 11413200; PMCID: PMC2193306.
    89. Paget-McNicol S, Saul A. Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. Parasitology. 2001 May; 122(Pt 5):497-505. PMID: 11393822.
      View in: PubMed
    90. Cloonan N, Fischer K, Cheng Q, Saul A. Aldolase genes of Plasmodium species. Mol Biochem Parasitol. 2001 Apr 06; 113(2):327-30. PMID: 11295188.
      View in: PubMed
    91. Huestis R, Cloonan N, Tchavtchitch M, Saul A. An algorithm to predict 3' intron splice sites in Plasmodium falciparum genomic sequences. Mol Biochem Parasitol. 2001 Jan 15; 112(1):71-7. PMID: 11166388.
      View in: PubMed
    92. Torres EP, Foley DH, Saul A. Ribosomal DNA sequence markers differentiate two species of the Anopheles maculatus (Diptera: Culicidae) complex in the Philippines. J Med Entomol. 2000 Nov; 37(6):933-7. PMID: 11126553.
      View in: PubMed
    93. Anders RF, Saul A. Malaria vaccines. Parasitol Today. 2000 Oct; 16(10):444-7. PMID: 11006477.
      View in: PubMed
    94. Taylor D, Cloonan N, Mann V, Cheng Q, Saul A. Sequence diversity in rodent malaria of the Pfs28 ookinete surface antigen homologs. Mol Biochem Parasitol. 2000 Oct; 110(2):429-34. PMID: 11071297.
      View in: PubMed
    95. Kirk KM, Eaves LJ, Meyer JM, Saul A, Martin NG. Twin study of adolescent genetic susceptibility to mosquito bites using ordinal and comparative rating data. Genet Epidemiol. 2000 Sep; 19(2):178-90. PMID: 10962477.
      View in: PubMed
    96. Modeling factors influencing malaria incidence in Myanmar. Southeast Asian J Trop Med Public Health. 2000 Sep; 31(3):434-8. PMID: 11288996.
      View in: PubMed
    97. Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother. 2000 Aug; 44(8):2100-8. PMID: 10898682; PMCID: PMC90020.
    98. Treatment of uncomplicated Plasmodium falciparum malaria in Myanmar: a clinical decision analysis. Southeast Asian J Trop Med Public Health. 2000 Jun; 31(2):238-45. PMID: 11127319.
      View in: PubMed
    99. Genton B, Al-Yaman F, Anders R, Saul A, Brown G, Pye D, Irving DO, Briggs WR, Mai A, Ginny M, Adiguma T, Rare L, Giddy A, Reber-Liske R, Stuerchler D, Alpers MP. Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea. Vaccine. 2000 May 22; 18(23):2504-11. PMID: 10775784.
      View in: PubMed
    100. Andrews KT, Walduck A, Kelso MJ, Fairlie DP, Saul A, Parsons PG. Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents. Int J Parasitol. 2000 May; 30(6):761-8. PMID: 10856511.
      View in: PubMed
    101. Lawrence N, Stowers A, Mann V, Taylor D, Saul A. Recombinant chimeric proteins generated from conserved regions of Plasmodium falciparum merozoite surface protein 2 generate antiparasite humoral responses in mice. Parasite Immunol. 2000 May; 22(5):211-21. PMID: 10792760.
      View in: PubMed
    102. Watson TM, Saul A, Kay BH. Aedes notoscriptus (Diptera: Culicidae) survival and dispersal estimated by mark-release-recapture in Brisbane, Queensland, Australia. J Med Entomol. 2000 May; 37(3):380-4. PMID: 15535581.
      View in: PubMed
    103. Figtree M, Pasay CJ, Slade R, Cheng Q, Cloonan N, Walker J, Saul A. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Mol Biochem Parasitol. 2000 Apr 30; 108(1):53-66. PMID: 10802318.
      View in: PubMed
    104. Johnson A, Leke R, Harun L, Ginsberg C, Ngogang J, Stowers A, Saul A, Quakyi IA. Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect Immun. 2000 Apr; 68(4):2231-6. PMID: 10722624; PMCID: PMC97408.
    105. Collins WE, Walduck A, Sullivan JS, Andrews K, Stowers A, Morris CL, Jennings V, Yang C, Kendall J, Lin Q, Martin LB, Diggs C, Saul A. Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys. Am J Trop Med Hyg. 2000 Apr; 62(4):466-79. PMID: 11220762.
      View in: PubMed
    106. Lawrence G, Cheng QQ, Reed C, Taylor D, Stowers A, Cloonan N, Rzepczyk C, Smillie A, Anderson K, Pombo D, Allworth A, Eisen D, Anders R, Saul A. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine. 2000 Mar 17; 18(18):1925-31. PMID: 10699342.
      View in: PubMed
    107. Ex post and ex ante willingness to pay (WTP) for the ICT Malaria Pf/Pv test kit in Myanmar. Southeast Asian J Trop Med Public Health. 2000 Mar; 31(1):104-11. PMID: 11023075.
      View in: PubMed
    108. Eisen DP, Saul A. Disappearance of pan-malarial antigen reactivity using the ICT Malaria P.f/P.v kit parallels decline of patent parasitaemia as shown by microscopy. Trans R Soc Trop Med Hyg. 2000 Mar-Apr; 94(2):169-70. PMID: 10897358.
      View in: PubMed
    109. Carter R, Mendis KN, Miller LH, Molineaux L, Saul A. Malaria transmission-blocking vaccines--how can their development be supported? Nat Med. 2000 Mar; 6(3):241-4. PMID: 10700212.
      View in: PubMed
    110. O'Donnell RA, Saul A, Cowman AF, Crabb BS. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species. Nat Med. 2000 Jan; 6(1):91-5. PMID: 10613831.
      View in: PubMed
    111. Saul A. The role of variant surface antigens on malaria-infected red blood cells. Parasitol Today. 1999 Nov; 15(11):455-7. PMID: 10511688.
      View in: PubMed
    112. Saul A, Lawrence G, Smillie A, Rzepczyk CM, Reed C, Taylor D, Anderson K, Stowers A, Kemp R, Allworth A, Anders RF, Brown GV, Pye D, Schoofs P, Irving DO, Dyer SL, Woodrow GC, Briggs WR, Reber R, Stürchler D. Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. Vaccine. 1999 Aug 06; 17(23-24):3145-59. PMID: 10462251.
      View in: PubMed
    113. Jakeman GN, Saul A, Hogarth WL, Collins WE. Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology. 1999 Aug; 119 ( Pt 2):127-33. PMID: 10466119.
      View in: PubMed
    114. Cheng Q, Cloonan N, Fischer K, Thompson J, Waine G, Lanzer M, Saul A. stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens. Mol Biochem Parasitol. 1998 Nov 30; 97(1-2):161-76. PMID: 9879895.
      View in: PubMed
    115. Saul A. Models for the in-host dynamics of malaria revisited: errors in some basic models lead to large over-estimates of growth rates. Parasitology. 1998 Nov; 117 ( Pt 5):405-7; discussion 409-10. PMID: 9836304.
      View in: PubMed
    116. Pyper WR, Tchavtchitch M, Saul A. The circumsporozoite protein of Plasmodium chabaudi contains a large, pre-region I repeat domain. Mol Biochem Parasitol. 1998 Aug 01; 94(2):287-9. PMID: 9747978.
      View in: PubMed
    117. Saul A. Malaria mortality: the pacific enigma-reply. Parasitol Today. 1998 Jul; 14(7):293-4. PMID: 17040790.
      View in: PubMed
    118. Tian JH, Good MF, Hirunpetcharat C, Kumar S, Ling IT, Jackson D, Cooper J, Lukszo J, Coligan J, Ahlers J, Saul A, Berzofsky JA, Holder AA, Miller LH, Kaslow DC. Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria. Parasite Immunol. 1998 Jun; 20(6):263-78. PMID: 9651928.
      View in: PubMed
    119. Foley DH, Bryan JH, Yeates D, Saul A. Evolution and systematics of Anopheles: insights from a molecular phylogeny of Australasian mosquitoes. Mol Phylogenet Evol. 1998 Apr; 9(2):262-75. PMID: 9562985.
      View in: PubMed
    120. Hyland CA, Chérif-Zahar B, Cowley N, Raynal V, Parkes J, Saul A, Cartron JP. A novel single missense mutation identified along the RH50 gene in a composite heterozygous Rhnull blood donor of the regulator type. Blood. 1998 Feb 15; 91(4):1458-63. PMID: 9454778.
      View in: PubMed
    121. Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol. 1997 Nov; 9(11):1723-33. PMID: 9418133.
      View in: PubMed
    122. Cheng Q, Lawrence G, Reed C, Stowers A, Ranford-Cartwright L, Creasey A, Carter R, Saul A. Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am J Trop Med Hyg. 1997 Oct; 57(4):495-500. PMID: 9347970.
      View in: PubMed
    123. Hafalla JC, Santiago ML, Pasay MC, Ramirez BL, Gozar MM, Saul A, Kaslow DC. Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum. Mol Biochem Parasitol. 1997 Jul; 87(1):97-9. PMID: 9233677.
      View in: PubMed
    124. Stowers A, Taylor D, Prescott N, Cheng Q, Cooper J, Saul A. Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2. Infect Immun. 1997 Jun; 65(6):2329-38. PMID: 9169771; PMCID: PMC175323.
    125. Pye D, Vandenberg KL, Dyer SL, Irving DO, Goss NH, Woodrow GC, Saul A, Alving CR, Richards RL, Ballou WR, Wu MJ, Skoff K, Anders RF. Selection of an adjuvant for vaccination with the malaria antigen, MSA-2. Vaccine. 1997 Jun; 15(9):1017-23. PMID: 9261951.
      View in: PubMed
    126. Cooper JA, Hayman W, Reed C, Kagawa H, Good MF, Saul A. Mapping of conformational B cell epitopes within alpha-helical coiled coil proteins. Mol Immunol. 1997 Apr; 34(6):433-40. PMID: 9307059.
      View in: PubMed
    127. Saul A, Lansang MA. Malaria in an area of low transmission in the Philippines. Acta Trop. 1997 Mar; 63(4):191-3. PMID: 9088433.
      View in: PubMed
    128. Torres EP, Salazar NP, Belizario VY, Saul A. Vector abundance and behaviour in an area of low malaria endemicity in Bataan, the Philippines. Acta Trop. 1997 Mar; 63(4):209-20. PMID: 9088435.
      View in: PubMed
    129. Saul A, Belizario VY, Bustos MD, Espino F, Lansang MA, Salazar NP, Torres E. Stability of malaria in a community in Bataan, the Philippines: prospects for control. Acta Trop. 1997 Mar; 63(4):267-73. PMID: 9088439.
      View in: PubMed
    130. Lansang MA, Belizario VY, Bustos MD, Saul A, Aguirre A. Risk factors for infection with malaria in a low endemic community in Bataan, the Philippines. Acta Trop. 1997 Mar; 63(4):257-65. PMID: 9088438.
      View in: PubMed
    131. Belizario VY, Saul A, Bustos MD, Lansang MA, Pasay CJ, Gatton M, Salazar NP. Field epidemiological studies on malaria in a low endemic area in the Philippines. Acta Trop. 1997 Mar; 63(4):241-56. PMID: 9088437.
      View in: PubMed
    132. Bustos MD, Saul A, Salazar NP, Gomes M. Profile of Morong, Bataan, an area of low malaria endemicity in the Philippines. Acta Trop. 1997 Mar; 63(4):195-207. PMID: 9088434.
      View in: PubMed
    133. Kun JF, Hibbs AR, Saul A, McColl DJ, Coppel RL, Anders RF. A putative Plasmodium falciparum exported serine/threonine protein kinase. Mol Biochem Parasitol. 1997 Mar; 85(1):41-51. PMID: 9108547.
      View in: PubMed
    134. Lawrence GW, Saul A, Giddy AJ, Kemp R, Pye D. Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720. Vaccine. 1997 Feb; 15(2):176-8. PMID: 9066035.
      View in: PubMed
    135. Hibbs AR, Stenzel DJ, Saul A. Macromolecular transport in malaria--does the duct exist? Eur J Cell Biol. 1997 Feb; 72(2):182-8. PMID: 9157015.
      View in: PubMed
    136. Saul A, Prescott N, Smith F, Cheng Q, Walliker D. Evidence of cross-contamination among laboratory lines of Plasmodium berghei. Mol Biochem Parasitol. 1997 Jan; 84(1):143-7. PMID: 9041530.
      View in: PubMed
    137. Stowers AW, Cooper JA, Ehrhardt T, Saul A. A peptide derived from a B cell epitope of Plasmodium falciparum rhoptry associated protein 2 specifically raises antibodies to rhoptry associated protein 1. Mol Biochem Parasitol. 1996 Nov 25; 82(2):167-80. PMID: 8946383.
      View in: PubMed
    138. Brandt ER, Hayman WA, Currie B, Carapetis J, Wood Y, Jackson DC, Cooper J, Melrose WD, Saul AJ, Good MF. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology. 1996 Nov; 89(3):331-7. PMID: 8958044; PMCID: PMC1456558.
    139. Beebe NW, Foley DH, Cooper RD, Bryan JH, Saul A. DNA probes for the Anopheles punctulatus complex. Am J Trop Med Hyg. 1996 Apr; 54(4):395-8. PMID: 8615454.
      View in: PubMed
    140. Rzepczyk CM, Stamatiou S, Anderson K, Stowers A, Cheng Q, Saul A, Allworth A, McCormack J, Whitby M, Olive C, Lawrence G. Experimental human Plasmodium falciparum infections: longitudinal analysis of lymphocyte responses with particular reference to gamma delta T cells. Scand J Immunol. 1996 Feb; 43(2):219-27. PMID: 8633202.
      View in: PubMed
    141. Gatton M, Hogarth W, Saul A, Dayananda P. A model for predicting the transmission rate of malaria from serological data. J Math Biol. 1996; 34(8):878-88. PMID: 8858854.
      View in: PubMed
    142. Jones GL, Spencer L, Lord R, Saul AJ. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2. Vaccine. 1996 Jan; 14(1):77-84. PMID: 8821653.
      View in: PubMed
    143. Foley DH, Beebe N, Torres E, Saul A. Misidentification of a Philippine malaria vector revealed by allozyme and ribosomal DNA markers. Am J Trop Med Hyg. 1996 Jan; 54(1):46-8. PMID: 8651368.
      View in: PubMed
    144. Relf WA, Cooper J, Brandt ER, Hayman WA, Anders RF, Pruksakorn S, Currie B, Saul A, Good MF. Mapping a conserved conformational epitope from the M protein of group A streptococci. Pept Res. 1996 Jan-Feb; 9(1):12-20. PMID: 8727479.
      View in: PubMed
    145. Mann VH, Law MH, Watters D, Saul A. The effects of bistratene A on the development of Plasmodium falciparum in culture. Int J Parasitol. 1996 Jan; 26(1):117-21. PMID: 9198587.
      View in: PubMed
    146. Stowers AW, Spring KJ, Saul A. Preparative scale purification of recombinant proteins to clinical grade by isotachophoresis. Biotechnology (N Y). 1995 Dec; 13(13):1498-1503. PMID: 9636309.
      View in: PubMed
    147. Stowers A, Prescott N, Cooper J, Takacs B, Stueber D, Kennedy P, Saul A. Immunogenicity of recombinant Plasmodium falciparum rhoptry associated proteins 1 and 2. Parasite Immunol. 1995 Dec; 17(12):631-42. PMID: 8834763.
      View in: PubMed
    148. Saul A. Computer model of the maintenance and selection of genetic heterogeneity in polygamous helminths. Parasitology. 1995 Nov; 111 ( Pt 4):531-6. PMID: 11023417.
      View in: PubMed
    149. Beebe NW, Saul A. Discrimination of all members of the Anopheles punctulatus complex by polymerase chain reaction--restriction fragment length polymorphism analysis. Am J Trop Med Hyg. 1995 Nov; 53(5):478-81. PMID: 7485705.
      View in: PubMed
    150. Sturchler D, Berger R, Rudin C, Just M, Saul A, Rzepczyk C, Brown G, Anders R, Coppel R, Woodrow G, et al. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults. Am J Trop Med Hyg. 1995 Oct; 53(4):423-31. PMID: 7485698.
      View in: PubMed
    151. Pasay MC, Cheng Q, Rzepczyk C, Saul A. Dimorphism of the C terminus of the Plasmodium vivax merozoite surface protein 1. Mol Biochem Parasitol. 1995 Mar; 70(1-2):217-9. PMID: 7637707.
      View in: PubMed
    152. Hibbs AR, Saul AJ. Plasmodium falciparum: highly mobile small vesicles in the malaria-infected red blood cell cytoplasm. Exp Parasitol. 1994 Nov; 79(3):260-9. PMID: 7957748.
      View in: PubMed
    153. Mann VH, Huang T, Cheng Q, Saul A. Sequence variation in the circumsporozoite protein gene of Plasmodium vivax appears to be regionally biased. Mol Biochem Parasitol. 1994 Nov; 68(1):45-52. PMID: 7891747.
      View in: PubMed
    154. Hyland CA, Wolter LC, Saul A. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes. Blood. 1994 Jul 01; 84(1):321-4. PMID: 7912557.
      View in: PubMed
    155. Cheng Q, Saul A. The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance. Mol Biochem Parasitol. 1994 Jun; 65(2):361-3. PMID: 7969277.
      View in: PubMed
    156. Cheng Q, Saul A. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol Biochem Parasitol. 1994 May; 65(1):183-7. PMID: 7935625.
      View in: PubMed
    157. Prescott N, Stowers AW, Cheng Q, Bobogare A, Rzepczyk CM, Saul A. Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker. Mol Biochem Parasitol. 1994 Feb; 63(2):203-12. PMID: 8008018.
      View in: PubMed
    158. Beebe NW, Foley DH, Saul A, Cooper L, Bryan JH, Burkot TR. DNA probes for identifying the members of the Anopheles punctulatus complex in Papua New Guinea. Am J Trop Med Hyg. 1994 Feb; 50(2):229-34. PMID: 8116817.
      View in: PubMed
    159. Hyland CA, Wolter LC, Liew YW, Saul A. A southern analysis of Rh blood group genes: association between restriction fragment length polymorphism patterns and Rh serotypes. Blood. 1994 Jan 15; 83(2):566-72. PMID: 7904488.
      View in: PubMed
    160. Cheng Q, Liu EX, Saul A. Peptides for inducing cross-reactive anti-malarial antibodies. Pept Res. 1994 Jan-Feb; 7(1):13-9. PMID: 7517231.
      View in: PubMed
    161. Lord R, Jones GL, Saul A. The influence of water-miscible alcohols on the conformation of antibodies directed against a defined epitope. Pept Res. 1994 Jan-Feb; 7(1):36-9. PMID: 7517232.
      View in: PubMed
    162. Lord R, Jones GL, Spencer L, Saul A. Mice immunized with a synthetic peptide construct corresponding to an epitope present on a Plasmodium falciparum antigen are protected against Plasmodium chabaudi challenge. Parasite Immunol. 1993 Nov; 15(11):613-8. PMID: 7533280.
      View in: PubMed
    163. Lord R, Jones G, Saul A. Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that crossreact with a nonhomologous 195-kDa malarial protein. Pept Res. 1993 Jul-Aug; 6(4):191-4. PMID: 8400614.
      View in: PubMed
    164. Cheng Q, Stowers A, Huang TY, Bustos D, Huang YM, Rzepczyk C, Saul A. Polymorphism in Plasmodium vivax MSA1 gene--the result of intragenic recombinations? Parasitology. 1993 May; 106 ( Pt 4):335-45. PMID: 8100358.
      View in: PubMed
    165. Saul A. Minimal efficacy requirements for malarial vaccines to significantly lower transmission in epidemic or seasonal malaria. Acta Trop. 1993 Jan; 52(4):283-96. PMID: 8094590.
      View in: PubMed
    166. Graves PM, Boreham R, Robert G, Fray L, Xu LJ, Huang YM, Relf W, Saul A, Kidson C. Antibody detection ELISAS for malaria diagnosis. Southeast Asian J Trop Med Public Health. 1992 Dec; 23(4):752-61. PMID: 1298085.
      View in: PubMed
    167. Saul A. Towards a malaria vaccine: riding the rollercoaster between unrealistic optimism and lethal pessimism. Southeast Asian J Trop Med Public Health. 1992 Dec; 23(4):656-71. PMID: 1298072.
      View in: PubMed
    168. Saul A, Yeganeh F, Howard RJ. Conservation of repeating structures in the PfEMP2/MESA protein of Plasmodium falciparum. Immunol Cell Biol. 1992 Oct; 70 ( Pt 5):353-5. PMID: 1478701.
      View in: PubMed
    169. Saul A, Yeganeh F, Howard RJ. Cloning and characterization of a novel multicopy, repetitive sequence of Plasmodium falciparum, REP51. Immunol Cell Biol. 1992 Oct; 70 ( Pt 5):357-9. PMID: 1339406.
      View in: PubMed
    170. Liu KY, Saul A. Molecular cloning of Plasmodium falciparum blood stage antigens and application of the recombinant proteins in serodiagnosis. Southeast Asian J Trop Med Public Health. 1992 Sep; 23(3):402-5. PMID: 1488692.
      View in: PubMed
    171. Saul AJ. Vaccine strategies for malaria: applicability in areas of seasonal or epidemic malaria. Southeast Asian J Trop Med Public Health. 1992 Sep; 23 Suppl 4:89-92. PMID: 1364872.
      View in: PubMed
    172. Naumann KM, Jones GL, Saul A, Smith R. Parasite-induced changes to localized erythrocyte membrane deformability in Plasmodium falciparum cultures. Immunol Cell Biol. 1992 Aug; 70 ( Pt 4):267-75. PMID: 1427985.
      View in: PubMed
    173. Cooper JA, Cooper LT, Saul AJ. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Mol Biochem Parasitol. 1992 Apr; 51(2):301-12. PMID: 1574088.
      View in: PubMed
    174. Rzepczyk CM, Csurhes PA, Saul AJ, Jones GL, Dyer S, Chee D, Goss N, Irving DO. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein. J Immunol. 1992 Feb 15; 148(4):1197-204. PMID: 1371134.
      View in: PubMed
    175. Doolan DL, Saul AJ, Good MF. Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development. Infect Immun. 1992 Feb; 60(2):675-82. PMID: 1730503; PMCID: PMC257683.
    176. Good MF, Saul A, Graves PM. Malaria vaccines. Biotechnology. 1992; 20:69-98. PMID: 1600390.
      View in: PubMed
    177. Saul A, Cooper J, Hauquitz D, Irving D, Cheng Q, Stowers A, Limpaiboon T. The 42-kilodalton rhoptry-associated protein of Plasmodium falciparum. Mol Biochem Parasitol. 1992 Jan; 50(1):139-49. PMID: 1542308.
      View in: PubMed
    178. Saul A, Lord R, Jones GL, Spencer L. Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. J Immunol. 1992 Jan 01; 148(1):208-11. PMID: 1727867.
      View in: PubMed
    179. Suhrbier A, Fernan A, Burrows SR, Saul A, Moss DJ. BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays. J Immunol Methods. 1991 Dec 15; 145(1-2):43-53. PMID: 1722495.
      View in: PubMed
    180. Pye D, Woodrow G, Saul A, Anders R. The development of a malaria vaccine. Australas Biotechnol. 1991 Dec; 1(3):151-4. PMID: 1367733.
      View in: PubMed
    181. Fernan A, Burrows SR, Moss DJ, Saul A, Suhrbier A. Inhibition of HLA B8-restricted recognition by unrelated peptides: evidence for allosteric inhibition. Immunol Lett. 1991 Nov; 30(3):339-44. PMID: 1724770.
      View in: PubMed
    182. Cheng Q, Jones G, Liu EX, Kidson C, Saul A. Identification of a common Plasmodium epitope (CPE) recognised by a pan-specific inhibitory monoclonal antibody. Mol Biochem Parasitol. 1991 Nov; 49(1):73-82. PMID: 1723149.
      View in: PubMed
    183. Suhrbier A, Rodda SJ, Ho PC, Csurhes P, Dunckley H, Saul A, Geysen HM, Rzepczyk CM. Role of single amino acids in the recognition of a T cell epitope. J Immunol. 1991 Oct 15; 147(8):2507-13. PMID: 1717563.
      View in: PubMed
    184. Jones GL, Edmundson HM, Lord R, Spencer L, Mollard R, Saul AJ. Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum. Mol Biochem Parasitol. 1991 Sep; 48(1):1-9. PMID: 1779984.
      View in: PubMed
    185. Limpaiboon T, Taylor DW, Jones G, Geysen HM, Saul A. Characterization of a Plasmodium falciparum epitope recognized by a monoclonal antibody with broad isolate and species specificity. Southeast Asian J Trop Med Public Health. 1991 Jun; 22(2):284. PMID: 1719648.
      View in: PubMed
    186. Jones GL, Spencer L, Lord R, Edmundson H, Saul AJ. High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2. Pept Res. 1991 May-Jun; 4(3):138-41. PMID: 1823184.
      View in: PubMed
    187. Jones GL, Lord R, Spencer L, Saul A. Comparative immunogenicity of free and carrier-conjugated peptides derived from the constant regions of a polymorphic malarial surface antigen. Immunol Lett. 1991 Mar; 27(3):209-14. PMID: 2060972.
      View in: PubMed
    188. Burkot TR, Da ZW, Geysen HM, Wirtz RA, Saul A. Fine specificities of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions. Parasite Immunol. 1991 Mar; 13(2):161-70. PMID: 2052404.
      View in: PubMed
    189. Jones GL, Spencer L, Mollard R, Saul A. Variable linking region immunogenicity using malarial peptide carrier protein conjugates of defined composition. Immunol Lett. 1990 Dec; 26(3):285-90. PMID: 2086458.
      View in: PubMed
    190. Saul A, Graves P, Edser L. Refractoriness of erythrocytes infected with Plasmodium falciparum gametocytes to lysis by sorbitol. Int J Parasitol. 1990 Dec; 20(8):1095-7. PMID: 2074138.
      View in: PubMed
    191. Lord R, Saul A. Adaptation of a Quackenbush hybridoma cell line to grow successfully in Balb/c mice. In Vitro Cell Dev Biol. 1990 Nov; 26(11):1028-9. PMID: 2276994.
      View in: PubMed
    192. Burkot TR, Graves PM, Paru R, Battistutta D, Barnes A, Saul A. Variations in malaria transmission rates are not related to anopheline survivorship per feeding cycle. Am J Trop Med Hyg. 1990 Oct; 43(4):321-7. PMID: 2240359.
      View in: PubMed
    193. Limpaiboon T, Taylor DW, Jones G, Geysen HM, Saul A. Characterization of a Plasmodium falciparum epitope recognized by a monoclonal antibody with broad isolate and species specificity. Southeast Asian J Trop Med Public Health. 1990 Sep; 21(3):388-96. PMID: 1706114.
      View in: PubMed
    194. Saul A, Battistutta D. Analysis of the sequences flanking the translational start sites of Plasmodium falciparum. Mol Biochem Parasitol. 1990 Aug; 42(1):55-62. PMID: 2233900.
      View in: PubMed
    195. Tindle RW, Zhou WD, Saul A, Frazer IH. The molecular specificity of linear B-epitopes in the E7 open reading frame protein of human papillomavirus 16 defined by monoclonal antibodies. Pept Res. 1990 Jul-Aug; 3(4):162-6. PMID: 1724617.
      View in: PubMed
    196. Jones GL, Spencer L, Lord R, Mollard R, Pye D, Saul A. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity. Immunol Lett. 1990 Jul; 24(4):253-60. PMID: 1697281.
      View in: PubMed
    197. Smythe JA, Peterson MG, Coppel RL, Saul AJ, Kemp DJ, Anders RF. Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum. Mol Biochem Parasitol. 1990 Mar; 39(2):227-34. PMID: 2181307.
      View in: PubMed
    198. Ho PC, Mutch DA, Winkel KD, Saul AJ, Jones GL, Doran TJ, Rzepczyk CM. Identification of two promiscuous T cell epitopes from tetanus toxin. Eur J Immunol. 1990 Mar; 20(3):477-83. PMID: 1690656.
      View in: PubMed
    199. Kara U, Murray B, Pam C, Lahnstein J, Gould H, Kidson C, Saul A. Chemical characterization of the parasitophorous vacuole membrane antigen QF 116 from Plasmodium falciparum. Mol Biochem Parasitol. 1990 Jan 01; 38(1):19-23. PMID: 1690855.
      View in: PubMed
    200. Saul A, Lord R, Jones G, Geysen HM, Gale J, Mollard R. Cross-reactivity of antibody against an epitope of the Plasmodium falciparum second merozoite surface antigen. Parasite Immunol. 1989 Nov; 11(6):593-601. PMID: 2482473.
      View in: PubMed
    201. Jones GL, Edmundson HM, Spencer L, Gale J, Saul A. The use of maleimidocaproyloxysuccinimide to prepare malarial peptide carrier immunogens. Immunogenicity of the linking region. J Immunol Methods. 1989 Oct 24; 123(2):211-6. PMID: 2478635.
      View in: PubMed
    202. Kara U, Pye D, Lord R, Pam C, Gould H, Geysen M, Jones G, Stenzel D, Kidson C, Saul A. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum. J Immunol. 1989 Aug 15; 143(4):1334-9. PMID: 2473129.
      View in: PubMed
    203. Jones GL, Gale J, Lord R, Edmundson HM, Saul A, Pye D. High titer response against a malarial antigen depends on the flanking sequence of the immunizing peptide conjugate. Pept Res. 1989 Jul-Aug; 2(4):282-5. PMID: 2520766.
      View in: PubMed
    204. Lew AM, Langford CJ, Anders RF, Kemp DJ, Saul A, Fardoulys C, Geysen M, Sheppard M. A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami. Proc Natl Acad Sci U S A. 1989 May; 86(10):3768-72. PMID: 2471191; PMCID: PMC287221.
    205. Cooper JA, Atkins A, Saul A. N-terminal amino acid sequencing of the 105 kilodalton rhoptry antigen of Plasmodium falciparum. Mol Biochem Parasitol. 1989 Mar 01; 33(2):203-4. PMID: 2657422.
      View in: PubMed
    206. Rock EP, Saul AJ, Taylor DW, Leech JH, Sherwood JA, Howard RJ. Expression of the histidine-rich protein PfHRP1 by knob-positive Plasmodium falciparum is not sufficient for cytoadherence of infected erythrocytes. Infect Immun. 1988 Dec; 56(12):3301-4. PMID: 3053455; PMCID: PMC259739.
    207. Saul A, Maloy WL, Rock EP, Howard RJ. A portion of the Pf155/RESA antigen of Plasmodium falciparum is accessible on the surface of infected erythrocytes. Immunol Cell Biol. 1988 Aug; 66 ( Pt 4):269-76. PMID: 3154921.
      View in: PubMed
    208. Cooper JA, Ingram LT, Bushell GR, Fardoulys CA, Stenzel D, Schofield L, Saul AJ. The 140/130/105 kilodalton protein complex in the rhoptries of Plasmodium falciparum consists of discrete polypeptides. Mol Biochem Parasitol. 1988 Jun; 29(2-3):251-60. PMID: 3045543.
      View in: PubMed
    209. Howard RJ, Barnwell JW, Rock EP, Neequaye J, Ofori-Adjei D, Maloy WL, Lyon JA, Saul A. Two approximately 300 kilodalton Plasmodium falciparum proteins at the surface membrane of infected erythrocytes. Mol Biochem Parasitol. 1988 Jan 15; 27(2-3):207-23. PMID: 3278227.
      View in: PubMed
    210. Saul A, Battistutta D. Codon usage in Plasmodium falciparum. Mol Biochem Parasitol. 1988 Jan 01; 27(1):35-42. PMID: 3278221.
      View in: PubMed
    211. Rock EP, Marsh K, Saul AJ, Wellems TE, Taylor DW, Maloy WL, Howard RJ. Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology. 1987 Oct; 95 ( Pt 2):209-27. PMID: 3320887.
      View in: PubMed
    212. Howard RJ, Lyon JA, Uni S, Saul AJ, Aley SB, Klotz F, Panton LJ, Sherwood JA, Marsh K, Aikawa M, et al. Transport of an Mr approximately 300,000 Plasmodium falciparum protein (Pf EMP 2) from the intraerythrocytic asexual parasite to the cytoplasmic face of the host cell membrane. J Cell Biol. 1987 May; 104(5):1269-80. PMID: 2437128; PMCID: PMC2114467.
    213. Saul A. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol. 1987 Jan; 9(1):1-9. PMID: 2436129.
      View in: PubMed
    214. Good MF, Quakyi IA, Saul A, Berzofsky JA, Carter R, Miller LH. Human T clones reactive to the sexual stages of Plasmodium falciparum malaria. High frequency of gamete-reactive T cells in peripheral blood from nonexposed donors. J Immunol. 1987 Jan 01; 138(1):306-11. PMID: 2431058.
      View in: PubMed
    215. Bushell GR, Cooper JA, Ingram LT, Schofield L, Saul A, Epping RJ, Chiu S, Jelacic S, Upcroft JA. Identification of key antigens of Plasmodium falciparum as vaccine candidates. P N G Med J. 1986 Mar; 29(1):69-73. PMID: 3529708.
      View in: PubMed
    216. Schofield L, Bushell GR, Cooper JA, Saul AJ, Upcroft JA, Kidson C. A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognized by inhibitory monoclonal antibodies. Mol Biochem Parasitol. 1986 Feb; 18(2):183-95. PMID: 2421161.
      View in: PubMed
    217. Saul A, Cooper J, Ingram L, Anders RF, Brown GV. Invasion of erythrocytes in vitro by Plasmodium falciparum can be inhibited by monoclonal antibody directed against an S antigen. Parasite Immunol. 1985 Nov; 7(6):587-93. PMID: 2419821.
      View in: PubMed
    218. Carter R, Bushell G, Saul A, Graves PM, Kidson C. Two apparently nonrepeated epitopes on gametes of Plasmodium falciparum are targets of transmission-blocking antibodies. Infect Immun. 1985 Oct; 50(1):102-6. PMID: 2412959; PMCID: PMC262142.
    219. Kidson C, Saul A, Schofield L, Upcroft J, Don M, Read D, Myler P, Castelino D, Chiu S, Ingram L. Selecting candidate antigens for malaria vaccines. Asian Pac J Allergy Immunol. 1984 Dec; 2(2):325-8. PMID: 6085274.
      View in: PubMed
    220. Ferrante A, Rzepczyk CM, Saul AJ. Polyamine oxidase-mediated trypanosome killing: the role of hydrogen peroxide and aldehydes. J Immunol. 1984 Oct; 133(4):2157-62. PMID: 6381596.
      View in: PubMed
    221. Lawrence G, Brown R, Bates J, Saul A, Davis M, Spark R, Anian G. An affinity technique for the isolation of Clostridium perfringens type C from man and pigs in Papua New Guinea. J Appl Bacteriol. 1984 Oct; 57(2):333-8. PMID: 6094417.
      View in: PubMed
    222. Saul A, Myler P, Schofield L, Kidson C. A high molecular weight antigen in Plasmodium falciparum recognized by inhibitory monoclonal antibodies. Parasite Immunol. 1984 Jan; 6(1):39-50. PMID: 6199717.
      View in: PubMed
    223. Rzepczyk CM, Saul AJ, Ferrante A. Polyamine oxidase-mediated intraerythrocytic killing of Plasmodium falciparum: evidence against the role of reactive oxygen metabolites. Infect Immun. 1984 Jan; 43(1):238-44. PMID: 6360897; PMCID: PMC263416.
    224. Hadley T, Saul A, Lamont G, Hudson DE, Miller LH, Kidson C. Resistance of Melanesian elliptocytes (ovalocytes) to invasion by Plasmodium knowlesi and Plasmodium falciparum malaria parasites in vitro. J Clin Invest. 1983 Mar; 71(3):780-2. PMID: 6338046; PMCID: PMC436930.
    225. Saul A, Myler P, Mangan T, Kidson C. Plasmodium falciparum: automated assay of erythrocyte invasion using flow cytofluorometry. Exp Parasitol. 1982 Aug; 54(1):64-71. PMID: 6807707.
      View in: PubMed
    226. Myler P, Saul A, Mangan T, Kidson C. An automated assay of merozoite invasion of erythrocytes using highly synchronized Plasmodium falciparum cultures. Aust J Exp Biol Med Sci. 1982 Feb; 60(Pt 1):83-9. PMID: 7046717.
      View in: PubMed
    227. Castelino D, Saul A, Myler P, Kidson C, Thomas H, Cooke R. Ovalocytosis in Papua New Guinea -- dominantly inherited resistance to malaria. Southeast Asian J Trop Med Public Health. 1981 Dec; 12(4):549-55. PMID: 7344104.
      View in: PubMed
    228. Lamont G, Saul A, Kidson C. Plasmodium falciparum: assay of invasion of erythrocytes. Exp Parasitol. 1981 Feb; 51(1):74-9. PMID: 6161838.
      View in: PubMed
    229. Saul A, Flores O, Novales J. Polymorphous light eruption: Treatment with thalidomide. Australas J Dermatol. 1976 Apr; 17(1):17-21. PMID: 938368.
      View in: PubMed
    Saul's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _